Safety profile of capecitabine as maintenance treatment after induction with XELOX or FOLFOX in metastatic colorectal cancer patients.

Cremolini, C; Moretto, R; Masi, G; Falcone, A

Cremolini, C; Moretto, R; Masi, G; Falcone, A.

Afiliación

Cremolini C; Department of Oncology, Polo Oncologico, Azienda Ospedaliero-Universitaria Pisana, Istituto Toscano Tumori, Pisa Department of Medical Oncology, University of Pisa, Pisa, Italy.
Moretto R; Department of Oncology, Polo Oncologico, Azienda Ospedaliero-Universitaria Pisana, Istituto Toscano Tumori, Pisa Department of Medical Oncology, University of Pisa, Pisa, Italy.
Masi G; Department of Oncology, Polo Oncologico, Azienda Ospedaliero-Universitaria Pisana, Istituto Toscano Tumori, Pisa Department of Medical Oncology, University of Pisa, Pisa, Italy.
Falcone A; Department of Oncology, Polo Oncologico, Azienda Ospedaliero-Universitaria Pisana, Istituto Toscano Tumori, Pisa Department of Medical Oncology, University of Pisa, Pisa, Italy alfredo.falcone@med.unipi.it.

Ann Oncol ; 27(9): 1810, 2016 09.

Article en En | MEDLINE | ID: mdl-27177861

Asunto(s)

Capecitabina; Fluorouracilo; Protocolos de Quimioterapia Combinada Antineoplásica; Neoplasias Colorrectales; Desoxicitidina/análogos & derivados; Fluorouracilo/análogos & derivados; Humanos; Leucovorina; Compuestos Organoplatinos; Oxaloacetatos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Capecitabina / Fluorouracilo Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2016 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google